Growing evidence of vaccine efficacy in long-term care fills gap left by COVID drug trials
May 26, 2021
Frail and elderly adults were systematically excluded from COVID vaccine trials. But now there are enough original studies involving long-term care residents to begin understanding how COVID vaccination...
Pfizer begins testing pneumonia vaccine with a COVID booster in seniors
By
Alicia Lasek
May 25, 2021
Trial participants — all aged 65 years and older — will be followed for six months to assess the safety of administering the two shots together and to track each vaccine’s effect on immunity,...
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
AMDA’s new COVID vaccine PowerPoint can help answer resident, staff concerns
By
Alicia Lasek
Dec 09, 2020
A toolkit created by industry clinicians aims to help long-term care operators address questions about getting vaccinated. A PowerPoint presentation is available to share with staff and residents.
COVID vaccine protects elderly; delivery program has buy-in from nearly all U.S. nursing homes
By
Alicia Lasek
Nov 19, 2020
Fully 99% of skilled nursing facilities nationwide have signed on with the federal Pharmacy Partnership for Long-Term Care Program vaccine delivery initiative, HHS says. The news arrived just as Pfizer...
Pfizer’s COVID vaccine more than 90% effective; key questions remain
By
Alicia Lasek
Nov 10, 2020
Trial participants received two injections about three weeks apart. There were 90% fewer COVID cases in those who received the vaccine when compared to those who received a placebo.
AstraZeneca’s COVID vaccine boosts immune response in older adults
By
Alicia Lasek
Oct 27, 2020
The experimental vaccine also reduced the risk of adverse events in older study participants, the drugmaker reports.
COVID trial vaccines may be inadequate, some FDA advisors fear
By
Alicia Lasek
Oct 26, 2020
The current vaccine trials may be too focused on mild rather than severe disease, some advisors contend. But their arguments got pushback in a meeting streamed on the agency’s YouTube channel.
CDC briefing: Top officials talk up vaccine plans, focus on long-term care
By
Alicia Lasek
Oct 22, 2020
Federal health officials touted transparency and nationwide distribution plans while keeping their eye on Phase 1 vaccine recipients, including LTC residents and workers.